Scholar Rock Holding Corporation
SRRK
Peringkat dalam Saham
#3423
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to... Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key program, SRK-181, is currently undergoing Phase 1 clinical assessment for tackling cancers that exhibit resistance to established checkpoint inhibitor treatments, including anti-PD-1 or anti-PD-L1 antibody therapies. Beyond these, the company cultivates a robust pipeline of innovative potential therapies, aiming to significantly improve the lives of individuals grappling with various severe ailments, such as neurological muscle conditions, malignancies, and fibrotic disorders. In a strategic partnership, Scholar Rock is collaborating with Gilead Sciences, Inc. to identify and develop targeted inhibitors of transforming growth factor beta (TGF-beta) activation, specifically for addressing fibrotic diseases. Established in 2012, Scholar Rock Holding Corporation operates from its headquarters in Cambridge, Massachusetts.
Harga Saham
$41.58
Kapitalisasi Pasar
$5.06B
Perubahan (1 hari)
3.34%
Perubahan (1 tahun)
48.94%
Negara
US
Perdagangan Scholar Rock Holding Corporation (SRRK)
Kategori
Healthcare
Jumlah saham beredar untuk Scholar Rock Holding Corporation (SRRK)
Jumlah saham beredar per June 2026: 130.61M
Menurut laporan keuangan terbaru dan harga saham Scholar Rock Holding Corporation, jumlah saham beredar saat ini adalah 130.61M. Pada akhir December 2023, perusahaan memiliki 75.98M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Scholar Rock Holding Corporation (SRRK) dari 2016 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 130.61M | 30.82% |
| 2024 | 99.84M | 31.40% |
| 2023 | 75.98M | 27.46% |
| 2022 | 59.61M | 62.38% |
| 2021 | 36.71M | 19.45% |
| 2020 | 30.73M | 11.61% |
| 2019 | 27.54M | 75.90% |
| 2018 | 15.66M | -12.57% |
| 2017 | 17.91M | 0.00% |
| 2016 | 17.91M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 253.90M | 94.39% |
US
|
|
| 396.00M | 203.19% |
US
|
|
| 478.91M | 266.67% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -52.39% |
NL
|
